Skip to content

Blood Transcript Analysis in Colorectal Cancer patients

Blood Transcript Analysis in Colorectal Cancer patients - Colontest

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43318
Enrollment
375
Registered
2016-08-17
Start date
2016-11-08
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon carcinoma

Interventions

None listed

Sponsors

Nederlands Kanker Instituut
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed colorectal cancer 2. Evaluable disease

Exclusion criteria

Exclusion criteria: 1. Patients with non-invasive colorectal cancer. 2. Patients undergoing local excision for colorectal cancer. 3. Known history of HIV seropositivity. 4. Patient with other malignancies

Design outcomes

Primary

MeasureTime frame
Blood CC12gene test signature to be an accurate test for diagnosis or for determination of status of disease and response to therapy with a sensitivity that exceeds that of current blood-based strategies (CEA).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)